Lung Cancer
Lung cancer is characterized by uncontrolled cell division in the lungs, leading to tumor growth and diminished breathing capacity. Cigarette smoking is the primary risk factor, while passive exposure to tobacco smoke can also cause lung cancer in non-smokers. The two main types are small-cell lung cancers (SCLC) and non-small-cell lung cancers (NSCLC). Diagnosis often occurs at advanced stages, impacting prognosis. Treatment may involve surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, and experimental approaches. The prognosis varies, with a 54% five-year survival for early-stage patients and 4% for advanced cases. Smoking cessation is crucial for prevention.
- Different types of lung cancer
- What are the symptoms of lung cancer?
- Stages of lung cancer
- Risk factors for lung cancer
- Lung cancer and smoking
- Diagnosing and treatment for lung cancer
- Diagnosing and treatment for lung cancer
Related Conference of Lung Cancer
15th International Conference on Pulmonary & Respiratory Medicine
4th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
16th International Conference on Chronic Obstructive Pulmonary Disease
Lung Cancer Conference Speakers
Recommended Sessions
- Advancements in Pulmonary Diagnostics
- Cardio Pulmonary Disorders
- Chronic Obstructive Pulmonary Disease
- COVID-19 and Asthma
- COVID-19 and Respiratory System
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Lung Cancer
- Lung Transplantation
- Obstructive Sleep Apnea
- Occupational Lung Diseases
- Pneumonia
- Pulmonary diseases: Treatment, Diagnosis and therapies
- Pulmonary Hypertension
- Pulmonary Rehabilitation
- Tuberculosis
Related Journals
Are you interested in
- Asthma - Tuberculosis-2024 (France)
- Asthma and Allergy - COPD CONGRESS 2024 (UK)
- Asthma and COPD - COPD_2024 (France)
- Atelectasis and Pneumothorax - Tuberculosis-2024 (France)
- Cardio Pulmonary Disorders - COPD CONGRESS 2024 (UK)
- Cardiopulmonary Disease - Tuberculosis-2024 (France)
- Chronic bronchitis - COPD CONGRESS 2024 (UK)
- Chronic Obstructive Pulmonary Disease - COPD_2024 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2024 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2024 (France)
- Co-Morbidities of COPD - COPD_2024 (France)
- COPD and Air Pollution - COPD CONGRESS 2024 (UK)
- COPD and Cardiovascular Diseases - COPD_2024 (France)
- COPD Complications - COPD_2024 (France)
- COPD Exacerbations - COPD_2024 (France)
- COPD Pathogenesis - COPD_2024 (France)
- COPD Pathogenesis - COPD CONGRESS 2024 (UK)
- COPD Therapeutics - COPD_2024 (France)
- COPD-Chronic obstructive pulmonary disease - COPD CONGRESS 2024 (UK)
- COPD: Sign and Symptoms - COPD_2024 (France)
- Depression and Anxiety in COPD - COPD CONGRESS 2024 (UK)
- Depression and anxiety in COPD - COPD_2024 (France)
- Diagnosis and Treatment of COPD - COPD CONGRESS 2024 (UK)
- Drug Discovery of COPD - COPD CONGRESS 2024 (UK)
- Drug Discovery of COPD - COPD_2024 (France)
- Effect of COVID-19 on Lungs - COPD CONGRESS 2024 (UK)
- Emphysema - COPD CONGRESS 2024 (UK)
- Epidemiology of COPD - COPD_2024 (France)
- Epidemiology of TB Disease - Tuberculosis-2024 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2024 (France)
- Genetic risk factor of COPD - COPD_2024 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2024 (France)
- Lung cancer - COPD_2024 (France)
- Lung cancer - COPD CONGRESS 2024 (UK)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - COPD CONGRESS 2024 (UK)
- Lung Function in Men with and without HIV - Tuberculosis-2024 (France)
- Lung Infection - Tuberculosis-2024 (France)
- Lung Transplantation - COPD CONGRESS 2024 (UK)
- Multidrug-resistant TB - Tuberculosis-2024 (France)
- Mycobacterial Infections - Tuberculosis-2024 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2024 (France)
- Pathophysiology of COPD - COPD_2024 (France)
- Pediatric Neonatal Care in COPD - COPD CONGRESS 2024 (UK)
- Pediatric Pulmonary, Critical care and Sleep - COPD_2024 (France)
- Pediatric Pulmonology & Critical care - COPD CONGRESS 2024 (UK)
- Prevention of COPD - COPD CONGRESS 2024 (UK)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2024 (France)
- Pulmonary diseases - COPD CONGRESS 2024 (UK)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2024 (France)
- Pulmonary diseases-treatment and therapies - COPD_2024 (France)
- Pulmonary Edema - Tuberculosis-2024 (France)
- Pulmonary Hypertension - COPD_2024 (France)
- Pulmonary Rehabilitation - COPD CONGRESS 2024 (UK)
- Respiratory and sleep Medicine - COPD CONGRESS 2024 (UK)
- Respiratory Failure and COPD Complications: - COPD CONGRESS 2024 (UK)
- Respiratory Tract Infections - COPD CONGRESS 2024 (UK)
- Self-Management and Prevention of COPD - COPD CONGRESS 2024 (UK)
- Self-Management and Prevention of COPD - COPD_2024 (France)
- Spirometry - COPD CONGRESS 2024 (UK)
- Stages & Severity on Lung Diseases - COPD CONGRESS 2024 (UK)
- TB Clinical Trials - Tuberculosis-2024 (France)
- TB Diagnosis, Prevention & Treatment - Tuberculosis-2024 (France)
- TB Vaccines - Tuberculosis-2024 (France)
- TB-HIV Co-infections - Tuberculosis-2024 (France)
- Tobacco control - COPD CONGRESS 2024 (UK)
- Types of COPD - COPD_2024 (France)
- Types of COPD - COPD CONGRESS 2024 (UK)
- Zoonotic TB - Tuberculosis-2024 (France)